JAK2 and myeloproliferative neoplasm: Our team also demonstrated for the first time the interaction between HSP27, JAK2, and STAT5, and the rise of HSP27 in patient samples, supporting the chaperoning role and the implication of HSP27 in MPN pathogenesis.